Neuromuscular Disease News and Research

RSS
Barrow Neurological Institute scientist receives grant to study myasthenia gravis

Barrow Neurological Institute scientist receives grant to study myasthenia gravis

MDA awards 42 medical researchers and labs over $21M for critical neuromuscular research

MDA awards 42 medical researchers and labs over $21M for critical neuromuscular research

Muscular dystrophy: $1M grant for study of erectile dysfunction drugs in improving muscle blood flow

Muscular dystrophy: $1M grant for study of erectile dysfunction drugs in improving muscle blood flow

Cardiologist receives grant to study impact of erectile dysfunction drugs on muscular dystrophy patients

Cardiologist receives grant to study impact of erectile dysfunction drugs on muscular dystrophy patients

Women riders support MDA's initiative on neuromuscular disease

Women riders support MDA's initiative on neuromuscular disease

PTC Therapeutics initiates additional clinical trial of ataluren in boys and young men with nmDBMD

PTC Therapeutics initiates additional clinical trial of ataluren in boys and young men with nmDBMD

microRNA-206 plays crucial role in the progression of ALS

microRNA-206 plays crucial role in the progression of ALS

Non-clinical data of CK-2017357 presented by Cytokinetics

Non-clinical data of CK-2017357 presented by Cytokinetics

Myasthenia Gravis Alliance receives Global Pharmaceuticals grant to further research and awareness

Myasthenia Gravis Alliance receives Global Pharmaceuticals grant to further research and awareness

UT physicians treat Iraqi girl with myasthenia gravis

UT physicians treat Iraqi girl with myasthenia gravis

Gene therapy increases muscle size and strength with no adverse effects in monkeys: MDA

Gene therapy increases muscle size and strength with no adverse effects in monkeys: MDA

Acceleron Pharma commences Phase 1 clinical study of its novel angiogenesis inhibitor

Acceleron Pharma commences Phase 1 clinical study of its novel angiogenesis inhibitor

CIRM awards Salk Institute $10.8M grant to develop stem-cell based therapy for Lou Gehrig's Disease

CIRM awards Salk Institute $10.8M grant to develop stem-cell based therapy for Lou Gehrig's Disease

Acceleron's Phase 1 trial of ACE-031 reveals its potential in treating neuromuscular diseases

Acceleron's Phase 1 trial of ACE-031 reveals its potential in treating neuromuscular diseases

Safeway raises funds to support neuromuscular disease medical research and therapies

Safeway raises funds to support neuromuscular disease medical research and therapies

Cytrx to submit revised protocol for arimoclomol Phase IIb clinical trial

Cytrx to submit revised protocol for arimoclomol Phase IIb clinical trial

Muscular Dystrophy Canada to host the 44th Jerry Lewis Labour Day Telethon

Muscular Dystrophy Canada to host the 44th Jerry Lewis Labour Day Telethon

Phase 1 single dose clinical trial of Acceleron Pharma's ACE-031 increases lean body mass

Phase 1 single dose clinical trial of Acceleron Pharma's ACE-031 increases lean body mass

Neuromuscular disorders common among Canadians

Neuromuscular disorders common among Canadians

New approach to remove toxic agent that causes myotonic dystrophy

New approach to remove toxic agent that causes myotonic dystrophy